We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.10 | -1.06% | 9.30 | 9.00 | 9.80 | 9.45 | 9.25 | 9.45 | 458,352 | 16:35:17 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -5.86M | -0.0057 | -16.49 | 97.46M |
Date | Subject | Author | Discuss |
---|---|---|---|
13/7/2023 08:18 | Interesting announcement. Not really what I expected.....not sure why that was considered necessary by the company - unless there is still some important inside info that isn't yet disclosed! | markingtime | |
13/7/2023 07:28 | That seems the most likely explanation as 6.7 million options expire at the end of this month and who isn’t going to exercise options at 4.5P when the current price is 10.5p | 888icb | |
13/7/2023 07:24 | Been on holiday this week. I assume yesterday was about stock being sold because of outstanding options expiring at end of month? | chillpill | |
13/7/2023 06:33 | Can you share the chart with wave predictions? Thanks. Well done with your analysis. | plasybryn | |
13/7/2023 06:28 | Yes, the past few days should have been a very sobering learning curve for the happy clappy crew over on LSE. I mean they have called the share price totally incorrectly for well over a decade, so they must have been aware that they had totally the wrong premise about what drives market prices. But now they have direct evidence that stock prices follow a set form or pattern which can be anticipated in advance. And even though they can't 'see' or understand that pattern at this stage...they are now aware that during bear markets, great company progress and lots of good news makes NO difference whatsoever to where the stock price heads . An important few days for PI's to experience here. The bear market should be close to its conclusion now and investor psychology will naturally swing positive from here. That means future good news from the company 'will seem' to have a beneficial effect. It really is all about human social behaviour. Anyone who's interested in how or why it happens should research the discipline of 'socionomics' which describes how natural swings in human mood controls much of our lives, including the people we elect and the way the world functions. Anyway, I'll leave you in peace now but may pop back from time to time. After all ..I'm a SCLP stock holder now. I think I bought inanaco's holding..lol | 2tyke | |
13/7/2023 06:25 | Tosh and Ivy. As ICB888 posts over there this morning - "no one lost anything today unless they sold." Further I have no wish to be involved in this squabble but wish to quietly add a matter of fact. The car park is there. It's large and tightly packed with vehicles. I'd be very surprised if it doesn't make pots of money. So what ? ATB | torquayfan | |
12/7/2023 21:29 | Nigel.... Google 'stock price capitulation in bear markets' You will discover it is a well known and expected phenomenon where many investors throw in the towel based on fear. It usually ends bear markets. Your post is nonsense. Neither the volume nor the fall in price is due to options ....sorry. | 2tyke | |
12/7/2023 20:49 | Agree that the upcoming options expiry likely explains the large volume and fall in price but funding will still be a worry and will be interesting to see if institutions mop up here or are willing to wait for the chance to get in lower down on an equity raise if needed. | nigelpm | |
12/7/2023 20:43 | It looks that cleaner is a true believer. | golcheja | |
12/7/2023 19:32 | Cleaner world...do wake up and smell the coffee dear .. Stock prices bring hope to NOBODY.... They are NOT companies. This simple FACT is at the heart of all the nonsense that you spout. Also ...selling options does NOT crash stock prices. Dear oh dear !! | 2tyke | |
12/7/2023 18:45 | Golcheja, I explained the requirement for a sharp sudden drop in the share price to end the current wave several days ago if you look back. Before even the recent RNS was issued. It's what happened. It's flushed out the weak bulls as the second wave retraced to the 0.618 fib. Anyone who puts forward an 'explanation' for this now is simply using hindsight conjecture and making up stories to 'kid themselves'. That's all it is. All about intellectual honesty. You have it...or you don't ! | 2tyke | |
12/7/2023 18:39 | The posts by Marking Times and 888ICB12 point up why, on top of an unloved cash burning sector, SCLP was hit harder following a pretty encouraging RHS (not particularly well expressed or supported by the interview). Not much sense from 2tyke, presumably one better than 1tyke, but lacking in knowledge or logic. But what is to be expected by an ex-Pharmacy worker making up prescriptions! | dominiccummings | |
12/7/2023 18:22 | Getting quick to 5p will close the door on some ability to profit from what is being unfold. | golcheja | |
12/7/2023 18:19 | Maybe it is in preparation for the NASDAQ float, very encouraging drive to single digit fiasco. | golcheja | |
12/7/2023 18:16 | Most important is to keep calm as soon nothing will be left to take off the table. Markus has a very good explanation for today drop is summary what a dump. | golcheja | |
12/7/2023 18:07 | It really doesn't matter to anyones investment inane... Neither here....or there ! | 2tyke | |
12/7/2023 17:36 | save you the trouble How long do you take KEYTRUDA infusions? Official answer. Keytruda (pembrolizumab) is a programmed death receptor-1 (PD-1)-blocking monoclonal antibody used to treat a number of different types of cancer. Keytruda is administered via a 30 min intravenous (IV) infusion every 3-6 weeks.9 Sept 2021 How long does it take for Keytruda to work? - Drugs.com Drugs.com hxxps://www.drugs.co Search for: How long do you take KEYTRUDA infusions? How long is a patient on KEYTRUDA? Some patients can stay on KEYTRUDA for up to a year or two. Your doctor will decide how long you will be on treatment. Always talk to your doctor about what to expect while taking KEYTRUDA. oh ? so you expect our trial to be 1 injection ... and 4 is excessive | inanaco | |
12/7/2023 17:32 | knowlesi how many infusions of Keytruda is given over a course ? | inanaco | |
12/7/2023 17:13 | Yes Roger, likely time for a top-up. So much rubbish spouted on BB's about the 'reasons' for price falls. There aren't any reasons. If there were the price wouldn't consistently hit predicted levels...nor would they get there in established regular patterns. It has been shown that even the largest imaginable trader in the smallest most illiquid stock couldn't manipulate a stock price by more than a fraction of a penny. And that would only last for minutes. You can forget option sales chaps....period ! | 2tyke | |
12/7/2023 16:38 | I agree with Marking Times earlier post. Lindy Durrant has 3850000 options at 4.5p which must be exercised by 30th July 2023. It therefore seems likely that she has been selling shares at 12p and less today in order to fund her purchase. Sell at 12p buy back at 4.5p provides a nice profit for her. She no doubt needed to put out the update so she wasn’t sitting on inside information when she sold. That to me seems the most likely explanation and if so the share price will rise again quickly. Alsoformer director Richard Goodfellow has to exercise his options and the company RNSed in April that they were creating 2.88 million shares to deal with his options. I note MT says 30th July for RG’s options also. I feel sure an RNS will appear shortly to explain the situation and that Shareholders should not be worried about todays shareprice fall. | 888icb | |
12/7/2023 15:25 | Time for a top up then | rogerbridge |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions